Illumina

Almac launches TruSight tumor profiling next-generation sequencing service

Wednesday, September 11, 2013 01:37 PM

Almac has launched a tumor profiling service running Illumina’s next-generation sequencing (NGS) TruSight Tumor panel as part of their biomarker discovery, development and delivery solutions.

More... »

Pathogenica, Illumina in co-marketing deal

Wednesday, July 17, 2013 12:30 PM

Pathogenica, a provider of medical diagnostic sequencing services and products, and Illumina have agreed to co-market in the Asia Pacific region a new version of Pathogenica's HAI BioDetection kit compatible with Illumina's MiSeq benchtop sequencing system. The combined solution will enable users to identify an expanded panel of bacteria and drug resistance genes present within clinical specimens and mixed cultures or isolates.

More... »

Partners HealthCare, Illumina announce founding members of GeneInsight Network

Monday, January 14, 2013 02:49 PM

Partners HealthCare, a Boston-based integrated health system, and Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, announced the GeneInsight-Illumina Founding Network Members, including the ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, New York Genome Center (NYGC), Partners HealthCare and Illumina.

More... »

Illumina strengthens reproductive health segment with acquisition of Verinata Health

Monday, January 7, 2013 10:26 AM

Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, has signed a definitive agreement to acquire Verinata Health, a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million, plus up to $100 million in milestone payments through 2015.

More... »

Knome introduces knoSYS100, first plug-and-play human genome interpretation system

Friday, September 28, 2012 12:10 PM

Knome, a Cambridge, Mass.-based provider of human genome interpretation systems and services, has launched its knoSYS100, the first plug-and-play, fully integrated hardware and software system designed to help researchers in medical and academic institutions interpret human whole genomes.

More... »

Illumina determines BaseSpace pricing for data storage and processing

Monday, July 30, 2012 03:22 PM

Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, has announced the pricing for BaseSpace, the company's genomics cloud computing and storage platform.

More... »

Roche will not extend offer for Illumina

Wednesday, April 18, 2012 11:00 AM

Roche has decided not to extend its tender offer for Illumina, based on preliminary estimates indicating the re-election of the incumbent directors of Illumina. Roche’s cash tender offer is due to expire on April 20, 2012 at 6 p.m. EST.

More... »

Roche disappointed with ISS recommendation

Monday, April 9, 2012 09:19 AM

The Institutional Shareholder Services (ISS) has recommended that shareholders of Illumina vote against the election of Roche’s independent director nominees to Illumina’s board of directors.

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »

Roche increases offer for Illumina $51 per share

Friday, March 30, 2012 09:17 AM

Roche has increased its offer price for all outstanding publicly-held shares of Illumina, $51 per share in cash. All other terms and conditions of the tender offer remain unchanged.

More... »